Where does Rajesh Devraj work?

Rajesh Devraj is Venture Partner at Atlas Venture.

What check size does Rajesh Devraj write?

Rajesh Devraj typically writes checks of $10M – $50M.

What boards does Rajesh Devraj sit on?

Rajesh Devraj holds tracked board seats at Antegrin Therapeutics, Antegrin Therapeutics, Euclises Pharmaceuticals.

Rajesh Devraj

Investor

Venture Partner at Atlas Venture

Cambridge, Massachusetts

Writes $10M – $50M checks · typically $25M

Find your path to Rajesh

318 people in our graph share verified history with Rajesh — schools, employers, funds. One of them is your warm intro.

Michael TaylorunlockedRajesh: together at Deciphera Pharmaceuticals (2014)

×4Rajesh: together at Pfizer Global Research and Development

×6Rajesh: together at Atlas Venture

Rajesh: together at Searle Discovery Research, Monsanto Life Sciences, Co.

Experience

Rectify PharmaceuticalsPresident & CEOcurrent2022 — presentCambridge, Massachusetts, United States
Washington University School of Medicine in St. LouisBiopharma Advisory Committeecurrent2023 — present
Euclises Pharmaceuticals Inc.Board Director2015 — 2025Greater St. Louis
Euclises Pharmaceuticals Inc.President and Chief Executive Officer2013 — 2014Greater St. Louis
Sail BIOBoard Director2021 — 2024Cambridge, Massachusetts, United States
Disarm TherapeuticsChief Scientific Officer and Co-founder2016 — 2020Cambridge, MA, USA
Indalo TherapeuticsBoard Director2017 — 2020Cambridge, Massachusetts, United States
Antegrin Therapeutics, LLCChairman of the Board of Managers2013 — 2016Greater St. Louis
Padlock Therapeutics Inc.Chief Scientific Officer2014 — 2016Cambridge, Massachusetts
Deciphera PharmaceuticalsScientific Advisory Board2012 — 2014
Deciphera PharmaceuticalsSenior Vice-President2011 — 2012Lawrence, Kansas, United States
Jubilant BiosysSenior Vice-President, Scientific & Portfolio Strategy2010 — 2011
Pfizer Global Research and DevelopmentSenior Director2004 — 2010
Pfizer Global Research and DevelopmentDirector2003 — 2004
Pfizer Global Research and DevelopmentAssociate Director & Science Research Fellow2002 — 2003
Pfizer Global Research and DevelopmentSenior Research Advisor and Section Head2000 — 2002
Searle Discovery Research, Monsanto Life Sciences, Co.Project & Technology Leader1997 — 2000
Searle Discovery Research, Monsanto Life Sciences, Co.Senior Research Investigator1996 — 1997

Skills & more

Strategic Planning4Drug Discovery96Medicinal Chemistry64Drug Design40Drug Development58Pharmaceutical Industry37Lead Change14CRO14Oncology10LC-MS13Biotechnology27Clinical Development20

+12 more

Organic ChemistryLifesciencesPharmacologyOrganic Synthesispreclinical developmentFundraisingCapital BudgetingImmunologyRInflammationAlliance-buildingClosing Deals

From Rajesh's professional profile.

Deals · 2

Antegrin TherapeuticsBoard seat

via Atlas Venture · filed Aug 2017 · $26M raise

Euclises PharmaceuticalsBoard seat

via Atlas Venture · filed Dec 2016 · $2.7M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Atlas Venture

Aimee Raleigh

Principal at Atlas Venture

Bruce Booth

Partner at Atlas Venture

Chelsea Johnson

Principal at Atlas Venture

David Grayzel

Partner at Atlas Venture

Dmitry Balyasny

General Partner at Atlas Venture

Jason Rhodes

Partner at Atlas Venture

Jean-Francois Formela

General Partner at Atlas Venture

Jean-François Formela

Partner at Atlas Venture

Frequently asked questions

Who is Rajesh Devraj?: Venture Partner at Atlas Venture
Where does Rajesh Devraj work?: Rajesh Devraj is Venture Partner at Atlas Venture.
What check size does Rajesh Devraj write?: Rajesh Devraj typically writes checks of $10M – $50M.
What boards does Rajesh Devraj sit on?: Rajesh Devraj holds tracked board seats at Antegrin Therapeutics, Antegrin Therapeutics, Euclises Pharmaceuticals.